Definitive Contract HHSN268200736186C
Award Date 10/31/06
Potential Completion Date 6/30/16
Potential Value $2.3M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Durham, NC 27710, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
18
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the Long Term Oxygen Treatment Trial, a research study funded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The contract, a Definitive Contract with cost-no-fee pricing, was awarded to The Johns Hopkins University, a private non-profit research university, on October 31, 2006, with a ceiling value of $15,824,931.90 and a completion date of April 30, 2017. The contract did not have a set-aside...
- This $229,949.71 federal contract award to Duke University was issued by the National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services. The contract, titled "BABY HUG FOLLOW-UP STUDY II", is a definitive contract with a cost-no-fee pricing type. The award has no set-aside designation and was issued on January 5, 2012 with an ultimate completion date of April 30, 2018. As the prime contractor, Duke University's Office of Research...
- The National Heart, Lung and Blood Institute of the National Institutes of Health, within the Department of Health and Human Services, awarded a $54,900 firm fixed price purchase order to Duke University Office of Research Administration Division. Under this contract, Duke University will provide analysis of hemoglobin adducts of polycyclic aromatic hydrocarbons to the National Institutes of Health located in Bethesda, Maryland. Work will be conducted over a one year period from December...
- The U.S. government awarded Duke University, a private non-profit educational institution, a $2,359,896.00 cost-no-fee definitive contract for biomedical (applied/exploratory) research and development services. This contract does not have a set-aside designation. Duke University's Office of Research Administration Division is serving as the prime contractor. The contract was awarded on September 17, 2003 with a completion date of April 30, 2005. This award is not associated with a larger...
- The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the U.S. government, has awarded a $11,816.00 firm fixed price purchase order to Duke University. The award will support Dr. Kam Ho's tuition fees for continuing courses in the NIH-Duke Master's program in which he is currently enrolled. The award has no set-aside designation. This purchase order award is part of Duke University's extensive portfolio of federal contract and grant awards, through which the...
- The National Institutes of Health (NIH) National Heart, Lung, and Blood Institute awarded a $11,936 firm fixed price purchase order to Duke University Office of Research Administration Division. The contract supports tuition fees for a researcher in the NIH-Duke Master's Program to continue taking courses. The program is a collaboration between NIH and Duke University to provide specialized training. Funding is provided by the Department of Health and Human Services NIH NHLBI. Performance will...
- This federal contract award was granted by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Duke University, a private university and non-profit organization. The $105,506.22 firm fixed-price purchase order is for a study or assessment, with a period of performance ending on May 1, 2017. The contract does not have a set-aside designation. Duke University has a robust track record of receiving federal contracts and grants from agencies such as the National...
- The U.S. Food and Drug Administration (FDA) has awarded a $1,567,108.00 definitive cost-no-fee contract to Duke University to conduct a study on Medicare Advantage for real-world evidence in cardiovascular disease. The contract has an ultimate completion date of September 29, 2026. Duke University, a prominent private research university, will be the prime contractor for this effort, which is not set aside under any special program. The contract award indicates Duke University's extensive...
- The National Heart Lung and Blood Institute (NHLBI), a Civilian agency, awarded a $154,439,309.43 Definitive Contract to the University of North Carolina at Chapel Hill (UNC-CH) on August 28, 1985 with a completion date of June 22, 2015. The contract is for biomedical research and services, and is not set-aside. UNC-CH, which operates under the name Office of Sponsored Research, is a major public research university with extensive experience managing large federal R&D projects across a range...
- This federal contract award to the University of Utah's Office of Sponsored Projects Division is for the "LONG TERM OXYGEN TREATMENT TRIAL" research project. The contract, valued at $3,021,197.02, is a definitive contract with a cost-no-fee pricing type and was awarded by the National Heart, Lung, and Blood Institute, a civilian agency within the Department of Health and Human Services. The contract does not have a set-aside designation. The University of Utah is the prime contractor...